I would expected accumulation and ramping over the next 6 to 8 weeks in anticipation again of the FDA phase 2 approval. Then a possible dump on that announcement. Be careful.
I have held VLA for over 4 years and so far have only seen continual dilution and SP pain for long term holders. Still VLA is many years away from realising its potential but CAVATAK looks promising so I continue to hold.
- Forums
- ASX - By Stock
- VLA
- viralytics granted chinese patent
viralytics granted chinese patent , page-4
Featured News
Add VLA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online